{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:45:16Z","timestamp":1778633116074,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2017,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.bbmt.2009.05.018","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T07:12:33Z","timestamp":1248333153000},"page":"1331-1336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Fernanda N.","family":"Villanueva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"P\u00e9rez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando F.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa T.","family":"Caballero-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fermin F.","family":"S\u00e1nchez-Guijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conzuelo C.","family":"Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes L.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores D.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas F.","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.05.018_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbmt.2006.03.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/00003495-200666080-00002","article-title":"Chronic graft-versus-host disease: pathogenesis and clinical management","volume":"66","author":"Perez-Simon","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2009.05.018_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbmt.2003.12.304","article-title":"Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"10","author":"Martin","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of graft-versus-host disease","volume":"43","author":"Ferrara","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2009.05.018_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V100.2.406","article-title":"Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood.V72.2.546.546","article-title":"Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation","volume":"72","author":"Sullivan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2009.05.018_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF01982622","article-title":"Affinities of glucocorticoids for glucocorticoid receptors in the human lung","volume":"17","author":"Rohdewald","year":"1986","journal-title":"Agents Actions"},{"key":"10.1016\/j.bbmt.2009.05.018_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bdd.2510110503","article-title":"Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate","volume":"11","author":"Wurthwein","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.bbmt.2009.05.018_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.0306-5251.2001.01374.x","article-title":"Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man","volume":"51","author":"Daley-Yates","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2009.05.018_bib14","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1182\/blood-2006-05-021139","article-title":"A\u00a0randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease","volume":"109","author":"Hockenbery","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib15","first-page":"166","article-title":"Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects","volume":"10","author":"Brogden","year":"1975","journal-title":"I: Asthma. Drugs"},{"key":"10.1016\/j.bbmt.2009.05.018_bib16","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/13543784.17.9.1389","article-title":"Beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease","volume":"17","author":"Diez-Campelo","year":"2008","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bbmt.2009.05.018_bib17","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/13543784.16.10.1709","article-title":"Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation","volume":"16","author":"McDonald","year":"2007","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bbmt.2009.05.018_bib18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbmt.2006.05.010","article-title":"Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD)","volume":"12","author":"Castilla","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0016-5085(98)70361-0","article-title":"Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial","volume":"115","author":"McDonald","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2009.05.018_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbmt.2005.04.008","article-title":"Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease","volume":"11","author":"Iyer","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib22","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2008.07.015","article-title":"Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the National Institutes Health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy","volume":"14","author":"Perez-Simon","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","article-title":"Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes","volume":"100","author":"Martino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.05.018_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428199609045715","article-title":"The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"24","author":"Ringden","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2009.05.018_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2007.11.1641","article-title":"Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival","volume":"26","author":"Valcarcel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2009.05.018_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2402550","article-title":"Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation","volume":"16","author":"Perez-Simon","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.05.018_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/bbmt.2002.v8.pm11846354","article-title":"A survey of diagnosis, management, and grading of chronic GVHD","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.05.018_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00007890-199512000-00010","article-title":"Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease","volume":"60","author":"Baehr","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.05.018_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:19Z","timestamp":1761057259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1083879109002602"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.018","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}